McKesson Reports Strong Fiscal 2026 Results and Announces Share Repurchase Program

Details

The company also announced a $2.25 billion accelerated share repurchase program and a $5.0 billion increase to its existing share repurchase authorization, bringing the total to $7.7 billion. Additionally, McKesson plans to separate its Medical-Surgical Solutions segment. The company provided fiscal 2027 adjusted earnings per diluted share guidance of $43.80 to $44.60, indicating 12% to 14% growth compared to the prior year.

Items reported

About McKesson Corporation

McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.